Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1677773
PUBLISHER: BCC Research | PRODUCT CODE: 1677773
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
PUBLISHED:
PAGES: 81 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
Report Scope
This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.
This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.
Report Includes
- Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
- Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
- An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
- Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
- Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
- Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments
Product Code: HLC304A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Reasons for Doing this Study
- Market Summary
Chapter 2 MENA Clinical Trial Industry Outlook
- Global Clinical Trial Market Overview
- MENA Share
- Evolving MENA Clinical Trial Industry
- Infrastructure and Resources: Bridging Gaps in Emerging Markets
- Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
- Cost-Effectiveness
- Regulatory Environment: Harmonization and Local Adaptations
- Government Support and Investments
- Impact of Regional Policies: Incentivizing Clinical Research
- Collaborations Expand Regional Networks
- Emerging Trends: Focus on Precision Medicine and Rare Diseases
- Growing Demand in Oncology and Rare Diseases
- Technological Advances: Digitalizing Clinical Operations
- Understanding the MENA Clinical Trial Landscape
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Regulatory Frameworks Driving Trial Feasibility
- Growing Patient Population Enhancing Recruitment and Diversity
- Technological Advances Streamlining Operations
- Collaborations
- Personalized Medicine Shaping Trial Design
- Market Challenges
- Complex Regulatory Landscape
- Limited Patient Recruitment and Retention
- Insufficient Infrastructure and Site Capacity
- Limited Adoption of Digital Technologies
- Competition for Key Therapeutic Areas
- Market Opportunities
- Regulatory Reforms Enabling Faster Approvals
- Emerging Focus on Oncology and Rare Diseases
- Public-Private Partnerships Boosting Research Capacity
- Focus on Precision Medicine and Genomics
Chapter 4 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis, by Sponsor Type
- Market Analysis, by Phase
- Market Analysis, by Service Type
- Market Analysis, by Study Type
- Market Analysis, by Therapeutic Area
Chapter 5 Emerging Markets
- Egypt
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- Kingdom of Saudi Arabia (KSA)
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- Lebanon
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- United Arab Emirates
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- Iran
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
Chapter 6 Russia-Ukraine War Impact Analysis
- Overview
- Supply Chain Disruptions
- Regulatory Challenges
- Patient Recruitment and Retention
- Geopolitical Risks
Chapter 7 Competitive Landscape
- Overview
- Competitive Landscape
- International CROs and Pharmaceutical Companies
- Local CROs and Institutions
- Academic and Research Institutions
- Mapping of Clinical Trial Product Services
- Recent Developments in Clinical Trials in the MENA Region
- Concluding Remarks from BCC
Chapter 8 Appendix
- Methodology
- Research Steps
- Sources
- Abbreviations
Product Code: HLC304A
List of Tables
- Summary Table : MENA Market for Clinical Trials, by Country, Through 2029
- Table 1 : MENA Clinical Trial Analysis, by Study Status, Through 2024
- Table 2 : Comparison of MENA Clinical Trial Regulations, Through 2024
- Table 3 : Comparison of MENA Clinical Trial Regulations, Through 2024
- Table 4 : MENA Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
- Table 5 : Regulatory Bodies for Conducting Clinical Trials in the MENA Region
- Table 6 : Recent Technological Advances in the MENA Clinical Trial Market, 2023 and 2024
- Table 7 : Recent Collaborations in the MENA Clinical Trial Market, 2024
- Table 8 : Recent Developments in Clinical Trial Infrastructure in MENA, 2023 and 2024
- Table 9 : Leading Causes of Death in MENA, by Country, 2021
- Table 10 : Recent Developments in the MENA Region, 2023 and 2024
- Table 11 : Recent Collaborations in the MENA Region, 2024
- Table 12 : Leading MENA Countries for Clinical Trials, by Sponsor Type, Through 2024
- Table 13 : MENA Market for Clinical Trials, by Sponsor Type, Through 2029
- Table 14 : Leading MENA Countries for Clinical Trials, by Phase, Through 2024
- Table 15 : MENA Market for Clinical Trials, by Phase, Through 2029
- Table 16 : MENA Market for Clinical Trials, by Service Type, Through 2029
- Table 17 : Leading MENA Countries for Clinical Trials, by Study Type, Through 2024
- Table 18 : MENA Market for Clinical Trials, by Study Type, Through 2029
- Table 19 : MENA Market for Clinical Trials, by Therapeutic Area, Through 2029
- Table 20 : Egyptian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
- Table 21 : Companies and Research Institutes for Clinical Trials in Egypt
- Table 22 : Egyptian Market for Clinical Trials, by Value, Through 2029
- Table 23 : Saudi Arabian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
- Table 24 : Companies and Research Institutes for Clinical Trials in the KSA
- Table 25 : Saudi Arabian Market for Clinical Trials, by Value, Through 2029
- Table 26 : Lebanese Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
- Table 27 : Companies and Research Institutes for Clinical Trials in Lebanon
- Table 28 : Lebanese Market for Clinical Trials, by Value, Through 2029
- Table 29 : UAE Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
- Table 30 : Companies and Research Institutes for Clinical Trials in UAE
- Table 31 : UAE Market for Clinical Trials, by Value, Through 2029
- Table 32 : Iranian Clinical Trials Analysis, by Study Status, Phase, Type, Results and Sponsor Type, Through 2024
- Table 33 : Companies and Research Institutes for Clinical Trials in Iran
- Table 34 : Iranian Market for Clinical Trials, by Value, Through 2029
- Table 35 : MENA Clinical Trials Product/Services Mapping Analysis
- Table 36 : Recent Developments in the MENA Clinical Trial Market, 2020-2024
- Table 37 : Information Sources in this Report
- Table 38 : Abbreviations Used in this Report
List of Figures
- Summary Figure : MENA Market for Clinical Trials, by Country, 2023-2029
- Figure 1 : Global Market for Clinical Trials, by Value, 2023-2029
- Figure 2 : Share of the Global Clinical Trials Market Value, by Region, 2023
- Figure 3 : Key Considerations for MENA Clinical Trials
- Figure 4 : Market Dynamics of Clinical Trial Infrastructure in the MENA Region
- Figure 5 : Share of Deaths, by Broad Cause, by Country, 2021
- Figure 6 : Share of MENA Market for Clinical Trials, by Sponsor Type, 2023
- Figure 7 : Share of MENA Market for Clinical Trials, by Phase, 2023
- Figure 8 : Share of MENA Market for Clinical Trials, by Service Type, 2023
- Figure 9 : Share of MENA Market for Clinical Trials, by Study Type, 2023
- Figure 10 : Share of MENA Market for Clinical Trials, by Therapeutic Area, 2023
- Figure 11 : Egyptian Market for Clinical Trials, by Value, 2023-2029
- Figure 12 : BCC Recommendations for the Egyptian Market for Clinical Trials
- Figure 13 : Saudi Arabian Market for Clinical Trials, by Value, 2023-2029
- Figure 14 : BCC Recommendations for Saudi Arabian Clinical Trials
- Figure 15 : Lebanese Market for Clinical Trials, by Value, 2023-2029
- Figure 16 : BCC Recommendations for Lebanese Clinical Trials
- Figure 17 : UAE Market for Clinical Trials, by Value, 2023-2029
- Figure 18 : BCC Recommendations for the UAE Clinical Trials
- Figure 19 : Iranian Market for Clinical Trials, by Value, 2023-2029
- Figure 20 : BCC Recommendations for the Iranian Clinical Trials
- Figure 21 : Share of MENA Market for Clinical Trials, by Stakeholder, 2024
- Figure 22 : Recommendations for Companies Looking to Enter the MENA Clinical Trial Market
- Figure 23 : Methodology Used in the MENA Clinical Trial Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.